Sean Khozin, MD, MPH

2024-02-28T15:24:44-06:00February 20, 2024|

Sean Khozin, MD, MPH, a physician-executive, board-certified oncologist, and data scientist with over 15 years of experience in therapeutic development, drug regulation, and the applications of artificial intelligence and machine learning in biomedical research. As the founder of Phyusion, Dr. [...]

Craig L. Tendler, MD

2024-02-27T17:26:36-06:00February 20, 2024|

Craig Tendler, M.D. is Vice President and Global Head of Clinical Development, Diagnostics, and Medical Affairs for the Oncology Therapeutic Area at Janssen Research & Development, one of the Janssen Pharmaceutical Companies of Johnson & Johnson. In this position, he [...]

Tara Frenkl, MD, MPH

2024-02-27T16:52:12-06:00February 20, 2024|

Tara Frenkl, MD, MPH is the Head of Oncology Development at Bayer’s Oncology Strategic Business Unit. Prior to joining Bayer, she held the role of Senior Vice President, Head of Medicine Development Leaders in Oncology at GlaxoSmithKline, with strategic impact [...]

Jean-Charles Soria, MD, PhD

2024-02-27T16:51:52-06:00February 20, 2024|

Jean-Charles Soria is Amgen’s Senior Vice President of Oncology within Global Development. Soria joined Amgen from Institut Gustave Roussy, where he was appointed director general by France’s Minister of Health and Solidarity. Soria is a medical oncologist and professor of [...]

Eliav Barr, MD

2024-02-27T16:51:26-06:00February 20, 2024|

Dr. Eliav Barr became head of Global Clinical Development (GCD) and Chief Medical Officer, Merck Research Laboratories (MRL), in April 2022. Previously he was Senior Vice President, Global Clinical Development and he has held positions of increasing responsibility including leadership [...]

Peter Sandor, MD, MBA

2024-02-27T16:49:57-06:00February 20, 2024|

Dr. Peter Sandor has 25 years of biopharmaceutical leadership experience and currently serves as the senior vice president, Primary Focus Lead, Primary Focus Immuno-oncology at Astellas.In his role, Dr. Sandor has responsibility for leading the strategic direction of Astellas’ early [...]

Stuart “Stu” Bailey, DPhil

2024-02-27T16:48:41-06:00February 20, 2024|

Stu Bailey is senior vice president, head of clinical measurement sciences at EMD Serono, Inc.. He previously served as vice president, head of analytics and data sciences at Biogen and global head of early development biostatistics at Novartis Institutes for [...]

Emily Morris-McCarthy

2024-02-27T16:48:07-06:00February 20, 2024|

Emily Morris-McCarthy is the general manager, head U.S. oncology for Sanofi. She previously served as franchise head for alliance/immuno-oncology and senior director of marketing for U.S. immuno-oncology marketing at Sanofi. Before coming to Sanofi, she was senior director of U.S. [...]

Brian Alexander, MD, MPH

2024-02-27T17:22:55-06:00February 20, 2024|

Brian Alexander, MD, was named Chief Executive Officer of Foundation Medicine in March 2021. He previously served as the company’s Chief Medical Officer, and practiced radiation oncology specializing in neuro-oncology at Dana-Farber Brigham Cancer Center. He is also a Senior [...]

William C. Weldon

2024-02-20T13:26:25-06:00February 20, 2024|

William C. Weldon is Chairman of the Board of Johnson & Johnson. He assumed his current responsibilities in April, 2002. Previously Bill served as Worldwide Chairman, Pharmaceuticals Group, and a Vice Chairman of the Board of Directors. He was elected [...]

Robert A. Bradway

2024-02-27T17:25:44-06:00February 20, 2024|

Robert A. Bradway is Amgen’s chairman and chief executive officer. Bradway became chairman in January 2013 and chief executive officer in May 2012. Bradway served as the company’s president and chief operating officer from May 2010 to May 2012, and [...]

Robert A. Ingram – In Memoriam

2024-02-20T13:21:07-06:00February 20, 2024|

Robert “Bob” Ingram (1942-2023) was General Partner at Hatteras Venture Partners, a venture capital firm that invests in early stage life science companies. Prior to joining Hatteras, Mr. Ingram was Chief Executive Officer and Chairman of Glaxo/Wellcome. Mr. Ingram co-led [...]

Scott White

2024-02-27T17:05:34-06:00February 20, 2024|

Scott White is Company Group Chairman, North America, at the Janssen Pharmaceutical Companies of Johnson & Johnson. A member of the Pharmaceuticals Group Operating Committee, he is responsible for leading Janssen’s efforts to transform the health of people in the [...]

Peter WT Pisters, MD, MHCM

2024-02-27T17:00:48-06:00February 20, 2024|

Peter WT Pisters, M.D., took the helm as president of The University of Texas MD Anderson Cancer Center in 2017, and forged a new path forward to end cancer by transforming the culture of the nation’s top-ranked cancer center. With a [...]

Norman “Ned” Sharpless, MD

2024-02-27T16:44:10-06:00February 20, 2024|

Dr. Sharpless led the National Cancer Institute (NCI) from 2017 to 2022. He was appointed acting commissioner of the U.S. Food and Drug Administration (FDA) in 2019 and served for seven months before returning to his position at the NCI. [...]

Major General Elder Granger, MD

2024-02-27T17:22:12-06:00February 20, 2024|

Since 2009, Major General Granger has been the President and CEO of THE 5Ps, LLC, a health care, education, and leadership consulting organization in Colorado. Prior to his retirement from the US Army in 2009, Dr. Granger served as the Deputy Director and [...]

John Crumpler

2024-02-27T17:21:46-06:00February 20, 2024|

John co-founded Hatteras in 2000 after a successful career as a technology entrepreneur. After a decade in politics and public policy, he was founder and CEO of E-Comm, Inc., a software development and services firm specializing in remote and mobile [...]

Go to Top